Prediction of , index 1719
Prospective Prediction
- Prediction Index
- 1719
- Prediction Date
- Commercial Prediction
- FAILURE (commercially insufficient clinical benefit in FVC inferior to pirfenidone)
- Technical Prediction
- partial SUCCESS (statistically maybe significant yet weak clinical benefit in FVC against placebo)
Readout of
Prediction Validation
- Readout Date
- Prediction To Readout
- 132 days in advance
- Readout Data Interpretation
- LYT100 550mg TID (equivalent to the approved pirfenidone 801 mg TID) achieved a 1.62% placebo-adjusted improvement in FVCpp; at least numerically inferior to the SoC (pirfenidone 801mg TID) that achieved a 1.97% placebo-adjusted improvement in FVCpp
- Press Release
- Press Release (businesswire.com)
Prediction Result
- Prediction Accuracy
- Correct Prediction
- Clinical Benefit Conclusion
- statistically significant yet weak (in FVCpp) and commercially insufficient (inferior to pirfenidone);
- Prediction Classification
- True Negative (TN)